ALSO READVivimed Labs spurts after unit successfully completes USFDA inspection Vivimed Labs Alathur unit completes successful USFDA visit Vivimed Labs provides update on scheme of amalgamation Vivimed Labs intimate of successful USFDA inspection of FDF facility in Alathur Vivimed Lab gains 8 pc on successful USFDA inspection
To form two joint venture companiesStrides Shasun has signed definitive agreements with Vivimed Labs to set up two joint venture companies, as under-
The 50:50 joint venture company in India will own the USFDA approved formulation facility in Alathur, Chennai and
The 50:50 joint venture company in Singapore through Strides Pharma Global, Singapore will own certain approved ANDAs and product pipeline.
The transaction is subject to customary closing conditions and expected to close by 31 May 2017.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)